Search
Now showing items 1-2 of 2
Humoral response after a BNT162b2 heterologous third dose of COVID- 19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
(Sociedad Japonesa de Vacunología, 2023-05)
Background: The inactivated virus vaccine, BBIBP-CorV, was principally distributed across low- and
middle-income countries as primary vaccination strategy to prevent poor COVID-19 outcomes. Limited
information is available ...
Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis
(International Society for Infectious Diseases, 2022-10)
Objectives: To identify differences in the clinical and epidemiologic characteristics of patients during the first and second waves of the COVID-19 pandemic at the EsSalud Lambayeque health care network, Peru.
Methods: ...